Phosphate Salt of Tricyclic Nucleoside

Suppliers

Names

[ CAS No. ]:
61966-08-3

[ Name ]:
Phosphate Salt of Tricyclic Nucleoside

[Synonym ]:
5-Methyl-1-(5-O-phosphono-b-D-ribofuranosyl)-1,5-dihydro-1,4,5,6,8-pentaazaacenaphthylen-3-amine
5-Methyl-1-(5-O-phosphono-β-D-ribofuranosyl)-1,5-dihydro-1,4,5,6,8-pentaazaacenaphthylen-3-amine
Pentaazaacenaphthylene-5' phosphate ester
3-Amino-1,5-dihydro-5-methyl-1-b-D-ribofuranosyl-1,4,5,6,8-pentaazaacenaphthylene 5'-(Dihydrogen Phosphate)
Phosphate Salt of Tricyclic Nucleoside
Triciribine phosphate (USAN)
1,4,5,6,8-Pentaazaacenaphthylen-3-amine, 1,5-dihydro-5-methyl-1-(5-O-phosphono-β-D-ribofuranosyl)-
VQD-002
TCN-P

Chemical & Physical Properties

[ Density]:
2.2±0.1 g/cm3

[ Boiling Point ]:
832.8±75.0 °C at 760 mmHg

[ Molecular Formula ]:
C13H17N6O7P

[ Molecular Weight ]:
400.28

[ Flash Point ]:
457.4±37.1 °C

[ Exact Mass ]:
400.089630

[ PSA ]:
200.81000

[ LogP ]:
-2.83

[ Vapour Pressure ]:
0.0±3.2 mmHg at 25°C

[ Index of Refraction ]:
1.925

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
RY8450000
CHEMICAL NAME :
1,4,5,6,8-Pentaazaacenaphthylen-3-amine, 1,5-dihydro-5-methyl-1-(5-O-phosphono-beta-D- ribofuranosyl)-
CAS REGISTRY NUMBER :
61966-08-3
LAST UPDATED :
198605
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C13-H17-N6-O7-P
MOLECULAR WEIGHT :
400.33

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
193 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) Volume(issue)/page/year: JAN1986
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
109 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) Volume(issue)/page/year: JAN1986

Related Compounds

  • SODIUM AMMONIUM HYDROGEN PHOSPHATE TETRAHYDRATE
  • Melamine salt of cage phosphate
  • tricyclohexylammonium salt of L-ascorbic acid 2-O-phosphate
  • tetrabutylammonim salt of diethylphosphoric acid
  • pyridinium salt of 2,3,4,6-tetra-O-acetyl α-D-glucopyranosyl phosphate
  • sodium salt of 2-bromophenol
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • methyl 2-[1-(5-bromo-2-pyridyl)-2-piperidyl]acetate
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • 3-(3-Amino-4-chloro-1H-pyrazol-1-YL)-1-methylpyrrolidin-2-one
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine